You are here

Expanding Access to Medicines

Bridging the Gap to Help Patients Get the Medicine They Need

Pfizer Corporate Responsibility develops programs that help expand global access to medicines by providing direct assistance to underserved populations. Our initiatives include providing product donations and steep discounts that help patients access the medicine they need. We also collaborate with Pfizer business teams and nonprofit organizations to help shape sustainable business models that address affordability and the vast differences in economies around the world.

These are the Signature Programs that Drive our Efforts

In 1998, Pfizer and the Edna McConnell Clark Foundation co-established the International Trachoma Initiative (ITI) to help end the suffering and poverty caused by trachoma, an infectious eye disease that causes blindness.
First launched in South Africa in 2000, the Diflucan Partnership Program helps provide treatment for AIDS-related fungal infections in developing countries around the world where HIV/AIDS is most prevalent.
The Pfizer Naloxone Access Program reflects Pfizer’s longstanding commitment to improve health outcomes by expanding access to medicines and ensuring patient safety through educational activities associated with appropriate use of prescription medicines.
For more than 25 years, Pfizer has empowered patients in need with assistance and information, so they can get access to the Pfizer medicines prescribed by their doctor. In the United States, Pfizer RxPathways® connects eligible patients to a full range of Pfizer assistance programs that enable them to access insurance support, co-pay help, and medicines for free or at a savings.

1 The Pfizer Foundation is a charitable organization established by Pfizer Inc. It is a separate legal entity from Pfizer Inc with distinct legal restrictions.